by： Meg Utterback   Aaron Wolfson

On September 4, 2019, the U.S. Department of the Treasury’s Office of Foreign Assets Control (OFAC) imposed sanctions on a shipping network it said was run by Iran’s Revolutionary Guards, alleging it sold millions of barrels of oil to benefit Syrian President Bashar al-Assad.  According to an advisory that OFAC issued the same day, the United States is targeting private and public sector entities around the world that engage in sanctionable conduct relating to shipping petroleum and petroleum products from Iran to Syria, China, and elsewhere.  OFAC is implementing these sanctions by adding 16 entities, 10 individual and 11 vessels suspected of being involved in such sanctionable activities to its List of Specially Designated Nationals and Blocked Persons (SDN List).  Among them was Mehdi Group, an India-based ship management company that OFAC alleges handles crewing and management of at least 7 of the vessels used in the Iranian oil smuggling network.  Continue Reading New Sanctions: Petroleum and petroleum product shipments to Iran

作者：  冯晓鹏  刘艺涵  王溢美  金杜律师事务所

在上篇文章【一文读懂新《药品管理法》对进口药品监督之影响（上）】中我们详细梳理了新《药品管理法》出台后海关对于境外药品在进口环节的监管要求与具体通关流程，并初步提示了药品进口过程中应当防范的“雷区”，本篇文章将以案说法，进一步分析药品进口责任主体在进口、销售环节可能面临的行政及刑事风险。

Continue Reading 一文读懂新《药品管理法》对进口药品监管之影响（下）

China Eastern Airlines Corporation Limited (“Eastern Airlines”, 600115. SH), which received CSRC’s approval, has recently made a private placement of A-shares and H-shares in an important move to respond to the deepening of China’s mixed ownership reform of SOEs and calls for strategic cooperation between state-owned and private sectors. Continue Reading King & Wood Mallesons advises China Eastern Airlines’ mixed ownership reform

近日，经中国证券监督管理委员会核准，中国东方航空股份有限公司（简称“东航股份”，A股股票代码：600115）向特定对象非公开发行A股及H股。此次非公开发行是东航股份响应国家深化国有企业混合所有制改革、加强国有资本和民营资本的战略合作号召的重要举措。 Continue Reading 金杜助力东航股份混合所有制改革

作者：刘斌  何春艳 刘盼  金杜律师事务所

商业实践中，隐名股东与名义股东之间没有书面股权代持协议的情况客观存在。在此情况下，隐名股东如何去主张代持法律关系，如何梳理证据材料去证实代持法律关系的存在？我们就此对最高院在股权代持纠纷审判实务中的裁判思路进行了梳理和研究。 Continue Reading 实锤干货 | 最高院股权代持纠纷裁判规则专题二：有无书面代持协议，那都不叫事儿

作者： 刘斌 何春艳 刘盼  金杜律师事务所

上两期专题我们就代持协议效力和事实上的代持法律关系相关问题进行了探讨。本期我们将聚焦于在代持法律关系有效成立的前提下，实际出资人如何“上位”，取代名义股东成为记载于股东名册或工商登记的股东，即通常所指的隐名股东显名化的问题。《最高人民法院关于适用〈中华人民共和国公司法〉若干问题的规定（三）》（下称“《公司法司法解释三》”）对有限责任公司隐名股东显名化的条件作出了明确规定——即需经“其他股东半数以上同意”。但是“其他股东半数以上同意”如何理解？是否有其他限制隐名股东显名化的障碍？股份有限公司隐名股东显名化如何进行？我们继续从梳理、解读最高院案例出发，对相关问题进行探讨，供批评指正。 Continue Reading 实锤干货—最高院代持纠纷裁判规则专题三：隐名股东如何“上位”？

作者：冯晓鹏 邓惠 王溢美   金杜律师事务所

 

2019年8月26日表决通过的《药品管理法》引起了广泛的关注和讨论，其中讨论最热烈的莫过于关于海淘“未经批准”的境外药品在境内转售不再按照“销售假药”处理。一直以来，进口或者购买境外药品入境都存在着巨大的市场和实际需求，但是，新版《药品管理法》真的为境外药品的进口/入境之路全程开了绿灯吗？在市场似乎广泛理解已经“高枕无忧”的当下，作为海关法的律师，我们认为还是有必要保持冷静态度，逐一厘清药品进口/入境的路径、监管要求，辨别新法实施后药品进口仍存在的“雷区”和“风险”。 Continue Reading 金杜医药板块法律主题月 | 一文读懂新《药品管理法》对进口药品监管之影响（上）

By Intan Eow (Partner), Kenny Cheok (Solicitor), KWM Sydney

Australia’s clean, green and natural food and agribusiness sector punches above its weight, producing enough food to feed approximately 60m people when its current population is just over 25m.  More than half of Australia’s food exports land in Asia (A$32bn out of a total of A$49bn in 2017-2018), including its single largest export destination, China (A$11.8bn).  Total foreign investment approvals in the agricultural sector increased year on year from $2.5bn in 2014 to $7.9bn in 2018.  Of these, China is the second largest foreign investor, with $1.6bn agricultural investments in 2017-2018. Continue Reading Recent food and agribusiness M&A in Australia – Toiling for nature’s gifts from the golden soil

作者：欧阳振远*

内容摘要 对违法行为行政处罚与刑事追究的界限问题一直以来是理论界与实务界关注的焦点。对涉嫌内幕交易的当事人在行政处罚程序和刑事调查程序中的不同法律评价，已经在行政处罚个案中直接适用。本文以“阳某某涉嫌内幕交易案”为研究对象，探讨了行政处罚证明标准的定义、实践、域外法域的做法，结合我国目前发展阶段的实际，提出了行政处罚的指导原则及不同情形下对证明标准的选择。

关键词 内幕交易 行政处罚 证明标准 刑事调查程序 Continue Reading 从“阳某某案”谈内幕交易行政处罚证明标准

by Huang Jianwen  King & Wood Mallesons

The newly revised Drug Administration Law (“New Law”) will come into effective on December 1, 2019.  Compared with the current Drug Administration Law, significant changes with respect to the framework and the specific content have been made in the New Law.  In response to the major issues in the current pharmaceutical industry, the New Law adopts several new systems, which are becoming more in line with international standards. For instance, the New Law establishes the drug marketing authorization holder system, the drug traceability system, the first accountability system, the innovation of evaluation and approval system, the unified quality management system for drug retail franchise operation and regulations of online drug sales etc.  Furthermore, the New Law cancels the Good Supplying Practice (“GSP”) and Good Manufacturing Practice (“GMP”) certifications and adopts stricter legal liabilities.  In addition, the New Law stipulates that entities or individuals importing a small amount of drugs without an importation certificate may be exempted from punishment. Continue Reading Major Changes in the Newly Revised Drug Administration Law